chrisvoncsefalvay/vaers-outcomes huggingface dataset:
can taste the vaccine, tastes kind of chemically; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administration date 05May2021 12:20 (Lot number: EW0173) at the age of 33 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Eczema" (ongoing), notes: Verbatim: Eczema; "Dyslexia" (unspecified if ongoing), notes: Verbatim: Dyslexia. Concomitant medication(s) included: CLOBETASOL PROPIONATE taken for eczema, start date: 2021 (ongoing). Past drug history included: Penicillin. Vaccination history included: Bnt162b2 (1ST Dose:7Apr2021. , Lot Number:EW0153), administration date: 07Apr2021, for COVID-19 IMMUNIZATION. The following information was reported: TASTE DISORDER (non-serious) with onset 05May2021, outcome "recovering", described as "can taste the vaccine, tastes kind of chemically".  Additional Information: Concomitant Clobetasol propionate he started using it 2 months ago. He stated his dermatologist thought that was eczema, and the steroid cream seemed to be working so they were thinking it was eczema. It was not officially diagnosed. No Investigation Assessment. He got the shot an hour ago and the taste started like 10 minutes ago. He stated it tasted kind of chemically, but he also had not eaten anything that day. It started 30 mins after he got the shot and had lasted for about 15 mins so far. He thought it was peaked and now going away. The patient had not received any other vaccinations within 4 weeks prior to Covid-19 vaccine.   No follow-up attempts are possible. No further information is expected.
Wasn't feeling really good; Body aches; Chills; A little bit of a headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Wasn't feeling really good), MYALGIA (Body aches), CHILLS (Chills) and HEADACHE (A little bit of a headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007c21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACECLOFENAC (ACENAC), METOPROLOL and ATORVASTATIN for an unknown indication.    On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jun-2021, the patient experienced MALAISE (Wasn't feeling really good), MYALGIA (Body aches), CHILLS (Chills) and HEADACHE (A little bit of a headache). At the time of the report, MALAISE (Wasn't feeling really good), MYALGIA (Body aches), CHILLS (Chills) and HEADACHE (A little bit of a headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included cyclodenpatarne. Treatment information was not provided.
Pt recv vax on 10/25/98; on same day pt exp LA pain & tingling, swelling, rash in deltoid region. It was reported that a 27-year-old female received FLUZONE SV '98-'99 USP on October 25, 1998. Reportedly that same day the patient expereinced a local reaction, tingling with difficulty grasping and rash on both arms. Follow-up #1 (28/Jun/2002): During internal reviewing of all files, it was deemed necessary to amend the report by updating the Adverse Event coding (added an AE-=DIFICULTY GRASPING and coded it to DYSKINESIA).
c/o of throat that was slightly itchy post vaccine.  no redness, swelling, and SOB noted.  symptoms resolved 3 mins. later.  advised mother to f/u with PCP if symptoms reoccured .  VS 113/76, O2 sat 98, R18, HR 99
none of the patients responded to PPV23; This literature marketed report has been received from the authors of a published literature article, titled as stated below and refers to a 40 year old female patient with chronic lymphocytic leukaemia. She received one course of antibiotics in the year before enrollment. There was no therapy prior to ibrutinib.  Pre-vaccination, the number of Streptococcus pneumoniae serotypes with immunoglobulin G (IgG) titers greater than 1.3 microgram/milliliter was 4. On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (lot #, expiration date, dose, route, and site of administration were not reported) for prophylaxis. Concomitant therapies included ibrutinib.  Post-vaccination, the number of Streptococcus pneumoniae serotypes with IgG titers greater than 1.3 microgram/milliliter was 1. The patient did not respond to pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (vaccination failure). The outcome of event was unknown. The authors considered vaccination failure to be related to pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown).  A copy of the published article is attached as further documentation of the patient's experience.  This is one of ten reports derived from the same literature article (cross referenced with MARRS# US-009507513-2103USA005447, US-009507513-2103USA005448, US-009507513-2103USA005449, US-009507513-2103USA005450, US-009507513-2103USA005451, US-009507513-2103USA005452, US-009507513-2103USA005453, US-009507513-2103USA005454, US-009507513-2103USA005455).  Company Causality Assessment: 2103USA005447; Sender's Comments:  US-009507513-2103USA005447: US-009507513-2103USA005448:Original Case : 2103USA003406 US-009507513-2103USA005449:Original Case : 2103USA003406 US-009507513-2103USA005450: US-009507513-2103USA005451: US-009507513-2103USA005452: US-009507513-2103USA005453: US-009507513-2103USA005454: US-009507513-2103USA005455:
Fever of 100 F. Chills. Tiredness. Body aches. Pain in spine. Pain and stiffness in arm where vaccine received.
Patient had a latex allergy to FLUVIRIN Multi-dose vials after Pharmacist confirmed with Novartis that it was latex free. Needle/syringe & glove was also latex-free. Patient had injection site rash & throat/tongue swelled up - was given BENADRYL at nurse's office.
Patient reported redness and itching approximately 30 minutes after receiving the vaccine. She was given benedryl and taken to the emergency room for follow-up. Blood pressure and vitals were monitored during the event.
Soreness in Arm started almost immediately.  Very tired throughout day. Then around 3:00PM arm got very sore and hurt to move.  At 12:15AM developed severe chills.  took tylenol and seems to be working
First dose-his pupils were dilated the evening of the shot.  They went back to normal the next morning.  Second dose-He has a sore arm, diarrhea, and a headache the day after the shot.
Lightheadedness/?floating feeling? starting 2-3 hours after vaccine lasting up to 3 days post vaccine Headache starting 4 hours post vaccine lasting up to 7 days post vaccine  Fever up to 102.8° starting 16 hours post vaccine up to 72 hours post vaccine  Sore arm starting 16 hours post vaccine lasting  up to 5 days post vaccine Body aches and cramps starting 24 hours post vaccine lasting up to 3 days post vaccine  Passing clots/abnormal menstruating starting day 6 post vaccine for 3 days Exacerbated palpitations/shortness of breath with minimal exertion starting 24 hours post vaccine lasting until present, much improved but still occasionally present 10/14: 8:40pm oculars in left eye, 9:50 left fingers then hand went numb, 9:52 left side of my face went numb, 9:55 resolved 10/20: left foot sugery
Itchy rash/ hives  neck area, trunk; Itchy rash/ hives  neck area, trunk; This is a spontaneous report from a contactable consumer (patient) reported that a 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246, expiration date: not reported), via an unspecified route of administration on the left arm on 08Jan2021 11:00 at single dose for COVID-19 immunization. Medical history included psoriasis and allergies to Penicillin; both from unknown dates. The patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine and rosuvastatin calcium (CRESTOR) taken from unspecified dates for unspecified indications. On 08Jan2021, the patient experienced itchy rash/hives neck area, trunk with outcome of recovering. As treatment, patient received Benedryl (as reported). Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible; information about lot number was already obtained.
?Moderna COVID-19 Vaccine EUA?  PATIENT GIVE EXPIRED VACCINE - TWO DAYS POST EXPIRATION
Fever, headache, nausea, rash, sore near injection spot, cold chills.
pt recvd vax 14JUN95 & 19JUN95 pt devel vesicles & gen rash;By 20JUN95 number of vesicles had inc to about 100;cont to break out;the nurse reported that according to pts father was exposed to varicella 10 to 14 days prior to breaking out
Vaccinated Friday mid morning. Developed fever of 103.6 Friday evening. Rash developed on Saturday along with vomiting and diarrhea.
Pt came to ER c/o chest pain with SOB.  Was positive for covid one month prior and was home with O2.
Patient starting feeling a tightness in her chest and was feeling like her heart was racing continue to feel "out of it'. Did not have trouble swallowing. As time progressed she continued to feel worse.
Pt sought medical help on 12/15/99 for continued flu-like symptoms (fever, chills, night sweats, fatigue, joint pain and body aches) and pruritic rash, which developed after receiving the 5th shot on 11/8/99. Pt initially had vasovagal reactions (flushed, diaphoretic, light-headed and tunnel vision) immediately after injection. Pt positioned in a seat and was under observation. No treatment was given at that time and pt recovered. Pt then developed serum-sickness like reaction and pruritic rash over hands and arms occurring 1 week, post vax, and lasting 6 weeks. Pt also stated he noted having dry eyes and blurry vision. Treated with prednisone and Zyrtec. Follow-up on 2/1/00, some symptoms improved with 2 weeks of bed rest but some are remaining; (blurry vision, joint pain, inability to concentrate and rash recurring). Pt had headache, joint pain and twitching, spasms in hip and low back but never reported on other vaccinations.
Throat irritation Narrative:  A few minutes after vaccine administration, while being monitored, provider was called to evaluate patient for increased heart rate,  nervousness and lightheadedness and scratchy throat 3 minutes after vaccination.  Nothing on the first vaccine. Hx of anxiety, no GERD and the scratchy throat scared him. T 98.7, R 16, P 97 and B/P 177/108. Last cigarette 1 hour ago, he at lunch (no caffeine or alcohol) and was hydrated with water. At 12:54 pm felt better just a nervous lump in his throat able to swallow water w/o difficulty and  no angioedema, rash or itching. P: 88, R 16, BP 148/86 . Had another glass of water and felt much better, all symptoms resolved. At 1:15 pm after additional monitoring time another set of vitals done - T 98, P 76, BP 135/81. Flagging PCP for continuity.
Administered vaccine but when took needle out of arm noticed the needle was not properly screwed on to syringe and some of the dose had leaked out onto patient's arm
Carotid Artery Dissection.   I woke up on 2/28 with a severe headache and general unwell feeling. I began to lose vision in one eye periodically and could hear a swishing noise in my ear.   I went to the ER where they did a CT scan and diagnosed me with a Carotid Artery Dissection and blood clot at the location.
Information has been received from a nurse concerning a 20 year old white female student who in August 2006, was vaccinated with a first dose of Gardasil. In August 2006, the patient developed discoloration and circular scarring. In November 2006, the patient was vaccinated with a second dose of Gardasil. At the time of the report, the patient's outcome was unknown. No further information is available.
This spontaneous report as received from a regulatory authority refers to a 2 year old male patient. On 20-JUL-2017 the patient was vaccinated with PNEUMOVAX 23 lot # M023823 for prophylaxis. On 20-JUL-2017, 5 hrs 42 min after onset of therapy the patient experienced urticaria. The outcome of urticaria was reported as recovered/resolved.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's pertinent medical history, drug allergies and concomitant medications were not reported. On 21-JUL-2016, the patient inadvertently received an expired dose of PNEUMOVAX 23 (lot# L00318, dose and route unknown) which had expired on 06-JUL-2016. This dose had also been improperly stored at 59F for 5 hours prior to the date of administration (date unspecified). No adverse effects were reported. Additional information has been requested.
PT HAD MILD NASAL CONGESTION & COUGH THAT BEGAN 3/16, WHICH SHE ATTRIBUTED TO SEASONAL ALLERGIES. SHE GOT HER 2ND PFIZER DOSE YESTERDAY (3/17), AND WITHIN A FEW HOURS DEVELOPED FEVER, CHILLS, MALAISE, MYALGIA, HEADACHE, SHORTNESS OF BREATH, AND WORSE COUGH & CONGESTION. SHE REPORTS A SIMILAR REACTION TO HER 1ST DOSE 2/25/22, WHICH KEPT HER BEDRIDDEN FOR A DAY OR SO. COVID AND FLU TESTS TODAY (3/19/22) WERE NEGATIVE. PT HAD COVID IN AUGUST 2021. SHE WAS PRESCRIBED AUGMENTIN IN CASE OF BACTERIAL INFECTION, PREDNISONE TO HOLD AND FILL IF WORSENING, AND TESSALON FOR COUGH. SHE WAS ADVISED TO RETURN TO CLINIC OR FOLLOW UP WITH PCP IF NO IMPROVEMENT, AND TO GO TO ER IF SEVERE WORSENING.
Diagnosed with Brachial Plexopathy. Severe pain from right shoulder down right arm to wrist.
This spontaneous report was received from a Medical Assistant refers to a 1 year old infant patient (gender unknown). On 20-JUL-2013, the 1 year old patient was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 (lot #, expiry not reported), intramuscularly. No adverse effects reported. Additional information has been requested.
Child received vaccines left/right thighs on 1/10/12, PENTACEL & varicella on (L). MMR by itself in (R) thigh. Mother called approx 48 hrs. later to describe large 5 inch x 5 inch area of redness on (L) anterior thigh, slightly warm to touch. Child came into office, assessed, diagnosed with cellulitis, started on KEFLEX, oral. Follow-up 1/13/12, 24 hours later: area significantly improved no pain, no warmth redness almost completely resolved.
Rash on back of both legs, after first injection. After second injection worsening of rash on both legs and abdomen - rash continued to worsen until received steroids - both Oral and Injection
Patient has been on egrifta .for 3 months now injected his shot last night Noticed redness at the site of the injection as soon as he injected egrifta which quickly spread throughout his arms trunk and face subsequently developing swelling of the mouth and tongue tongue and buccal mucosa remained swollen for approximately 1 hour patient laid down took no medication no Benadryl no steroid and symptoms resolved. Of note the patient received Moderna vaccine on  Saturday
PATIENT CALLED PHARMACY 10/9/23 STATING SHE HAD A FEVER THE NIGHT OF THE VACCINE 10/4/23 FOR FLUAD AND COMIRNATY.  FEVER WENT AWAY THE SAME NIGHT.  NEXT DAY 10/5/23, PATIENT STATED SHE FELT DIZZY, PINS/NEEDLES SENSATION ON LEFT ARM/LEG, AND HEAVY/NUMBNESS FEELING IN LEFT ARM/LEGS.  MOST OF THE SYMPTOMS SUBSIDED BY 10/8/23.  CURRENTLY ONLY EXPERIENCING HEAVY/NUMBNESS FEELING IN LEFT LEG.  PATIENT STATES DID NOT CONTACT PCP OR WENT TO THE ER EITHER.
PT EXPERIENCED LIGHT HEADEDNESS AND FAINTED ALMOST IMMEDIATELY AFTER RECEVING FLUBLOK VACCINE,  LIED THE PATIENT ON THE FLOOR , ELEVATED FEET. CALLED 911 AND TOOK HER TO HOSPITAL
Immediately post vax, the pt developed a fever of 100 and a swollen arm with redness and warmth to touch at the injection site. It was noted that the swelling is confined to the arm. At the time of reporting, the pt's swollen arm and fever persisted.
Headache, Myalgia, Arthralgia & Fever Narrative: employee with mild symptoms, which caused her to missed one day of work
Diarrhea and green stools with mucous, occurring 8-12 x a day that began 3 days after getting rotavirus vaccine.
erythema & swelling mid deltoid to elbow; Atarax 25 qid & cool soaks
Vaccine given a beyond use date of  3:30pm and vaccine administered approximately 30 minutes past the BUD time of 3:30pm
Injection on 10/18 along with flu shot on left arm. 10/19 low grade fever, slight swelling and pain but not horrible. Progressively got worse and went to urgent care on 10/22. Arm was swollen huge and very painful to touch.
Intense debilitating shoulder pain. Stiff rotator cuff, frozen shoulder, unable to lift arm without severe pain.
not constant but very consistent pain/area of the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (not constant but very consistent pain/area of the shot) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049c21a and 041c21a) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus. Concomitant products included METFORMIN and ATORVASTATIN for an unknown indication.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (not constant but very consistent pain/area of the shot). At the time of the report, VACCINATION SITE PAIN (not constant but very consistent pain/area of the shot) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pain assessment (other-Unknown): (abnormal) pain a 9 in a scale of 1 to 10.         Patient used medication for diabetes  Treatment medication was not provided by the reporter  Patient had experienced very consistent pain a 9 in a scale of 1 to 10
This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. On 28-NOV-2018, the patient was administered impoperly stored ROTATEQ for prophylaxis lot #R013289 and expiration date 03-OCT-2019 and lot #N030152 and expiration date 01-SEP-2019 (strength, dose, frequency and route of administration were not reported). No adverse effects were reported. The lowest temperature of excursion was below 36°F / 2°C (34.9°F) for 28 minutes including below 32°F for 15 minutes. There was no previous temperature excursion. There was no digital data logger involved. This is one of several reports received from the same reporter.; Sender's Comments: US-09507513-1901USA007858:
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 05-SEP-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5 ml, lot # K005957, expiration date 08-MAR-2015, route unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 2064 hours with lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Prolonged menstrual bleeding starting 2 weeks after booster. This lasted 4 months and ended with hysterectomy.
Felt very shaky, eyes were burning and runny, throat raw and felt swollen. Later took Benadryl and it relieved symptoms.
Worsening of primary exertional headache; now requires less exertion to trigger symptoms.
12 hours after vaccination symptoms started including severe chills, no fevers, several hours later no chills but did have body aches and no fever or N/V. Next day still achy by six to eight almost back to normal took Tylenol PM and slept for several hours then the next day started to develop on the inside of elbows and inner thighs, stomach and chest with  hives and rash and probably back to include the palms that were red and itchy this lasted pronounced for 3 days and is still persistent with itch but rash is resolving.  Client started taking Benadryl every six hours ended taking them 4 days later.
Hard knot at injection, red circle about 2 inch in diameter,  hot to the touch, the knot had swelling, stretched skin so that it was painful, and would get chilled all over body.
Skin Lesion Information has been received from a health care professional concerning a 12 month old female with no pertinent medical history or allergies who on approximately 26-SEP-2005, 1 1/2 weeks ago was vaccinated SC in the thigh with a 0.5ml dose of varicella virus vaccine live (Oka/Merck). On 05-OCT-2005 the patient presented to the clinic with an"oozing lesion at the injection site". It was unknown what treatment was given. No product quality complaint was involved. No further information was available. Follow up information from the health professional indicated that the child never came into the office to have a reaction check. The reporter explained to the mother that if the child got worse to come into the office. She never got a follow up call so she is assuming the child got better over the next couple of days. This is all the information available. Additional information is not expected.
This spontaneous report as received from a medical assistant refers to an unspecified number patient of unknown age. The patients' pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored VARIVAX (lot # M008171 and expiry date 16-FEB-2018) subcutaneous. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
Legs went rubbery when walking on treadmill, speaking was slow and deliberate (not slurred). Facial expression and hand grip was normal. Lasted about 1-2 minutes. About 12 hours later, difficulty walking, could not perform fine hand movements to control mouse curser, Facial expression and hand grip was normal. Lasted about 10 minutes but on way to ER at medical center. See Item 19 for more information
Information has been received from a registered nurse referring to unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (lot # L018499, expiration date 25-FEB-2017; dose and route of administration were not provided). No adverse events were reported. Follow up information has been received from the registered nurse on 06-NOV-2015. The nurse reported that on unknown dates, the doses of improperly stored VAQTA (lot # K012457, expiration date 04-JUN-2017) (dose and route were not reported) were also administered to unspecified number of patients. Follow up information has been received on 30-DEC-2015. All telephone attempts to obtain follow-up information have been unsuccessful. Follow-up information was received on 07-JAN-2016 from the registered nurse. On 26-OCT-2015, the patient of unknown age and gender was vaccinated with a dose of VAQTA (lot # L018499, expiration date 25-FEB-2017; dose and route were not reported) that was involved in the temperature excursion. The nurse confirmed that no adverse events were reported. This is one of several reports received from the same source. Additional information has been requested. Patient tab, product tab, event tab and analysis were updated.
Starting noticing large amounts of hair loss when washing my hair.  My hair has started just falling out by the handful.  This wasn?t happening prior to first CoVid vaccination. Normal hair loss but not the amount I?m seeing now.